April 06, 2020 (GLOBE NEWSWIRE) — GW Pharmaceuticals announced today that it had received notification from the United States Drug Enforcement Administration (DEA) confirming that EPIDIOLEX® (cannabidiol) is no longer subject to the Controlled Substances Act (CSA). This change takes effect immediately.
“This notification from DEA fully establishes that EPIDIOLEX, the only CBD medicine approved by FDA, is no longer a controlled substance under the federal Controlled Substances Act,” said Justin Gover, GW’s Chief Executive Officer. “We would like to thank DEA for confirming the non-controlled status of this medicine. Importantly, the descheduling of EPIDIOLEX has the potential to further ease patient access to this important therapy for patients living with Lennox-Gastaut Syndrome and Dravet syndrome, two of the most debilitating forms of epilepsy.”
EPIDIOLEX, which was launched in the United States on November 1, 2018 after approval by FDA for the treatment of seizures associated with Lennox-Gastaut Syndrome (LGS) or Dravet syndrome in patients two years of age or older, is the first prescription pharmaceutical formulation of highly purified, plant-derived cannabidiol (CBD), and the first in a new category of anti-epileptic drugs.
Following FDA approval, EPIDIOLEX was initially placed in Schedule V of the CSA. Following receipt of this DEA notification, GW has filed a post-approval supplement with FDA to remove Schedule V designation from EPIDIOLEX.
DEA’s letter means that all federal controlled-substance restrictions have been removed for EPIDIOLEX. The Company will now begin the process of implementing these changes at the state level and through the EPIDIOLEX distribution network. Once this process is completed in each state, prescriptions for EPIDIOLEX, like other non-controlled medicines, will be valid for one year and can be easily transferred between pharmacies. The descheduling of EPIDIOLEX also enables physicians to prescribe this breakthrough medicine free of the requirements of state prescription drug monitoring programs.
Descheduling will enable prescribing free of the previous Schedule V requirements
How Much Does It Cost?
https://www.drugs.com/price-guide/epidiolex
Recent Posts
- Rescheduling Marijuana Would Be a Huge Threat to Public Health
Kevin Sabet of Smart Approaches to Marijuana says policy makers need to learn from their mistakes with hemp when considering marijuana rescheduling. It’s rare for… Read more: Rescheduling Marijuana Would Be a Huge Threat to Public Health - Industrial Cannabis Sativa Hemp Plastic-Updates
Hemp plastic which is 100% biodegradable, can be a better alternative to synthetic plastic. This review paper updates the benefits of using hemp fibre for… Read more: Industrial Cannabis Sativa Hemp Plastic-Updates - Federal Court says Gun Ban For Cannabis Consumers Is Unconstitutional
A federal appeals court has ruled that the ban preventing people who use marijuana from possessing firearms is unconstitutional. The U.S. Court of Appeals for… Read more: Federal Court says Gun Ban For Cannabis Consumers Is Unconstitutional - Edibles recalled in MI containing 200 mg of THC per serving
MICHIGANS CANNABIS REGULATORY AGENCY NOTIFIES CONSUMERS OF VOLUNTARY MARIJUANA PRODUCT RECALL July 07, 2023 In the interest of public health and safety, the Cannabis Regulatory… Read more: Edibles recalled in MI containing 200 mg of THC per serving - Is Growing Hemp in Michigan Legal?
The Michigan Department of Agriculture and Rural Development (MDARD) administers the hemp cultivation program and oversees Industrial Hemp Grower Registration and the Cannabis Regulatory Agency (CRA) administers the hemp processing… Read more: Is Growing Hemp in Michigan Legal?
